DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,630 Cr | ₹2,411 Cr | ₹2,345 Cr | ₹2,310 Cr | ₹1,633 Cr |
What is the latest Total Liabilities ratio of DR LAL PATHLABS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,630 Cr |
| Mar2024 | ₹2,411 Cr |
| Mar2023 | ₹2,345 Cr |
| Mar2022 | ₹2,310 Cr |
| Mar2021 | ₹1,633 Cr |
How is Total Liabilities of DR LAL PATHLABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,630 Cr | 9.09 | |
| Mar2024 | ₹2,411 Cr | 2.81 | |
| Mar2023 | ₹2,345 Cr | 1.53 | |
| Mar2022 | ₹2,310 Cr | 41.41 | |
| Mar2021 | ₹1,633 Cr | - | |
Compare Total Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹24,839.2 Cr | 3.3% | -4.6% | -3.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹101,645.0 Cr | -3.1% | -10.4% | -8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹101,262.0 Cr | -1.2% | -4.7% | -2.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,704.3 Cr | -2.5% | -4.4% | 31.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,643.6 Cr | -2.4% | -5.9% | 41.7% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,877.2 Cr | -2.9% | -7.4% | 4.2% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 3.3% |
-4.6% |
-3.1% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses